hydroxychloroquine has been researched along with Reperfusion Injury in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to determine the neuroprotective effects of hydroxychloroquine (HCQ) and the timing of its administration in cerebral ischemia/reperfusion (I/R) in rats." | 8.31 | Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion. ( Babataheri, S; Malekinejad, H; Mosarrezaii, A; Soraya, H, 2023) |
| " The aim of the present study was to determine the neuroprotective effects of hydroxychloroquine (HCQ) and the timing of its administration in cerebral ischemia/reperfusion (I/R) in rats." | 4.31 | Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion. ( Babataheri, S; Malekinejad, H; Mosarrezaii, A; Soraya, H, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Babataheri, S | 3 |
| Malekinejad, H | 3 |
| Mosarrezaii, A | 3 |
| Soraya, H | 3 |
| Zhang, S | 1 |
| Zhang, Q | 1 |
| Wang, F | 1 |
| Guo, X | 1 |
| Liu, T | 1 |
| Zhao, Y | 1 |
| Gu, B | 1 |
| Chen, H | 1 |
| Li, Y | 1 |
| Tang, TT | 1 |
| Lv, LL | 1 |
| Pan, MM | 1 |
| Wen, Y | 1 |
| Wang, B | 1 |
| Li, ZL | 1 |
| Wu, M | 1 |
| Wang, FM | 1 |
| Crowley, SD | 1 |
| Liu, BC | 1 |
3 other studies available for hydroxychloroquine and Reperfusion Injury
| Article | Year |
|---|---|
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain Ischemia; Hydroxychloroquine; Infarction; N | 2023 |
Hydroxychloroquine inhibiting neutrophil extracellular trap formation alleviates hepatic ischemia/reperfusion injury by blocking TLR9 in mice.
Topics: Animals; Disease Models, Animal; Extracellular Traps; Hydroxychloroquine; Liver; Male; Mice; Mice, I | 2020 |
Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cathepsin B; Cathepsin L; Cell Line; Cell Su | 2018 |